WillItSurvive
Consumer brands · United States

Prose

Prose sells customized shampoo, conditioner, and skincare made to order from an online quiz.

Losing its protection
Assessed 23 July 2026 · Evidence as of 23 July 2026
The structural protection is eroding.
On the recordSince 23 July 2026 · Checkable from H2 2026 · Every call on the record Checkpoint: Next funding round, or a L'Oréal/Estée Lauder personalized-haircare product launch
The call

Prose has real revenue and real factories, but no fresh funding since 2021 and giants circling personalized beauty leave its position unsettled.

Prose mixes shampoo and conditioner to order based on what customers tell them about their hair, then ships it to homes. The company has real factories, real sales of about $165 million a year, and nine years of notes on hair formulas. But this is not hard for giants like L'Oréal or Estée Lauder to copy: they already own factories, have their own scientists, and are buying up smaller beauty-tech companies right now. The one thing that could save Prose is if it builds such a loyal customer base or such a fast operation that the big companies decide it is cheaper to buy them than to build it themselves, but so far Prose has not raised new money since around 2021, which suggests either the company does not need it or cannot get it at a good price.

Why
01
AI pressure: Generic AI beauty-diagnostic quiz tools, including L'Oréal's own AI skin/hair tools. AI quizzes can copy Prose's diagnostic front end, but can't replicate its made-to-order factories. Could AI do the core job? Only partly.
02
Bigger players: L'Oréal, Estée Lauder. Both have labs and cash to clone personalized formulas and are buying beauty-tech startups instead of building from scratch. Could a giant copy it? Probably.
03
What protects it. Nine years of proprietary formulation data plus owned Brooklyn and LA factories making 30k custom units a day.
What would change this call
L'Oreal or Estee Lauder launches a competing personalized-haircare subscription within 12 months. Would show incumbents can replicate Prose's model and target its customers directly.
Prose announces a new funding round or is acquired by a conglomerate. Up-round signals strength; a strategic buyout or down-round signals the standalone bet is weakening.
Prose or Function of Beauty discloses 2025-26 revenue growth figures. Deceleration from 2024's +29% would show category or company momentum is fading.
Key numbers
  • 2024 revenue $165M, up 29% YoY (2024)
  • No new funding round in about 94 months (2026-06)
  • Headcount down 6% YoY to 280 employees (2026-06)
Named risks
  • No new funding round since ~2021, raising questions about ability to raise at prior valuation. Severity: high
  • Incumbent beauty conglomerates (L'Oreal, Estee Lauder) actively acquiring beauty-tech and could replicate personalization model. Severity: high
  • All revenue and growth figures are company self-reported with no independent audit or financial filing. Severity: medium
  • Headcount flat to declining (-6% YoY as of June 2026) even as revenue reportedly grows. Severity: medium
  • Category peer Function of Beauty needed restructuring in 2023, signaling possible sector-wide fragility. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
L'Orealgaining onCompleted Kering Beaute acquisition March 2026, agreed Innovist stake June 2026, active beauty-tech M&A
Estee LaudercontestingNamed as incumbent capable of replicating personalization diagnostics, not structurally barred as of 2026
Function of Beautygaining onProse's closest DTC rival underwent restructuring and layoffs in 2023, a category warning sign
Questions people ask
Is Prose profitable in 2026?
Prose has not disclosed independently audited profitability figures. The company self-reports 2024 revenue of $165M with 29% year-over-year growth as of June 2025, but no funding round, IPO filing, or audited financials confirm actual net profit or margin.
Could AI replace Prose's haircare business?
AI could commoditize Prose's quiz-based diagnostic front-end, since generic AI personalization tools can replicate consultation logic. But Prose's made-to-order manufacturing, including its Brooklyn facility and new $9M Los Angeles center opened June 2025, cannot be replicated by software alone.
Who owns Prose?
Prose is privately held, founded 2016-2017 by Arnaud Plas, Nicolas Mussat, Catherine Taurin, and Paul Michaux, former L'Oreal and Phyto executives. Its last reported funding round was a Series C at a company-reported $905.63M valuation around September 2021, with no new round confirmed since.
Is L'Oreal a threat to Prose?
Yes. L'Oreal is not structurally barred from personalized haircare and has been acquisitive in beauty-tech, completing the Kering Beaute acquisition in March 2026 and agreeing to acquire a majority stake in Innovist in June 2026, signaling appetite to consolidate the personalization space Prose pioneered.
Who is Prose's biggest competitor?
Function of Beauty is Prose's most frequently cited direct DTC rival, though it underwent restructuring and layoffs in 2023. The larger structural threat is incumbent beauty conglomerates like L'Oreal and Estee Lauder, which have far greater resources and active M&A activity in beauty-tech as of 2026.
Has Prose raised new funding recently?
No. As of June 2026, data tracker Crustdata reported Prose had gone roughly 94 months without a new funding round, with its last reported raise being a Series C at a company-reported $905.63M valuation around September 2021.
Timeline
  • 2026-06L'Oreal agrees to acquire majority stake in Indian beauty startup Innovist
  • 2026-06Crustdata reports Prose headcount at 280, down 6% YoY, no funding round in 94 months
  • 2026-03L'Oreal completes acquisition of Kering Beaute
  • 2025-06Prose opens 43,000 sq ft West Coast customization center in Commerce, California, $9M investment
  • 2025-04Prose launches first Custom Scalp Serum using 85+ personalization factors
  • 2024-04Prose publicly unveils Singular, its AI beautytech platform used internally since 2017
  • 2023-06Prose debuts AI-powered personalized skincare line with 15M+ formula combinations
  • 2021-09Prose closes Series C round at company-reported $905.63M valuation
  • 2018-11Prose raises $18M Series B led by Insight Venture Partners
  • 2017-12Prose raises $5.2M Series A led by Forerunner Ventures
Revision history
23 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources